Sunday, May 25, 2025

CATEGORY

Recall

DIGEMID Orders Immediate Withdrawal of Propofol HLB Anesthetic

The National Directorate of Medicines, Food Safety and Supplements (DIGEMID) has issued an urgent alert mandating the immediate removal of all Propofol HLB anesthetic...

Peruvian Health Authority Warns Against Fake YERVOY Drug in Collaboration with Mexican Regulator

The Peruvian Directorate General of Medicines, Ingredients, and Medical Devices (DIGEMID) has issued a critical alert regarding the counterfeit distribution of YERVOY (Ipilimumab) 50...

Advanced Accelerator Withdraws Lutathera Expansion Request

Advanced Accelerator Applications has officially retracted its bid to broaden the approval of Lutathera for treating newly diagnosed gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs). This decision...

DIGEMID Takes Action Against Shaddai Medicina Orgánica for Unregistered Sales

The Peruvian regulatory authority, DIGEMID, has issued Alert No. 61-2025 targeting Shaddai Medicina Orgánica for the unlawful sale of sanitary products. The company allegedly...

Safety Alert Issued to Medtronic for Evolution Valve Opening Issues

The Spanish Agency of Medicines and Medical Devices (AEMPS) alongside France’s National Agency for the Safety of Medicines and Health Products (ANSM) have released...

Regulators Warn VNS Therapy SenTiva Models Could Fail Treatment

Health authorities in Spain and the United Kingdom have issued urgent safety warnings concerning specific serial numbers of the VNS Therapy SenTiva devices. These...

Regulatory Agencies Warn of Safety Issues in UHI-4 High-Flow Insufflation Unit

The Spanish Agency of Medicines and Medical Devices (AEMPS) alongside the UK's Medicines and Healthcare products Regulatory Agency (MHRA) have issued critical safety warnings...

DIGEMID Withdraws Metamizol Sódico and Doloferbil Batches Over Quality Concerns

The Peruvian Directorate General of Medicines, Supplies, and Drugs (DIGEMID) announced the removal of specific batches of Metamizol Sódico and Doloferbil from the market...

FDA Halts Ingestible Fluoride Products for Children

The U.S. Food and Drug Administration (FDA) has taken decisive steps to remove concentrated ingestible fluoride prescription drugs intended for children from the marketplace....

FDA Bans Swallowed Fluoride Drugs for Children to Protect Gut Health

The U.S. Food and Drug Administration has announced measures to eliminate concentrated ingestible fluoride prescription drugs intended for children. This decision targets products that...

Insulin Pump Shortages Impacting Diabetes Care Across EU

Healthcare providers across the European Union are bracing for potential shortages of essential insulin pump cartridges as Novo Nordisk announces manufacturing constraints. Patients relying...

DIGEMID Cracks Down on Unregistered Dietary Products Online

The National Directorate of Medicines, Supplies, and Drugs (DIGEMID) has issued Alert No. 56-2025, targeting the illegal sale of dietary products without proper sanitary...

DIGEMID Alerts Falsified HEALMOXY Amoxicillin in Africa

Peruvian health authorities, DIGEMID, have issued a critical alert regarding the detection of counterfeit HEALMOXY (amoxicillin) 500 mg capsules within the African region, as...

Health Authorities Crack Down on Fake Diagnostic Devices in Major Seizure

Peruvian health regulators have taken decisive action against counterfeit medical diagnostic devices, resulting in the seizure of multiple fraudulent products from the market. This...

Peruvian Health Authority Pulls KARCITRON from Market Over Safety Concerns

The Peruvian General Directorate of Medicines, Supplies and Drugs (DIGEMID) has initiated the removal of KARCITRON pharmaceutical products from the market following critical quality...

Latest news